N/A

Loading page data
Please wait a moment
Second Floor, 150 Fleet Street,
London, EC4A 2DQ.
+44 203-837-5656
108 W 39th Street, Ste 1006,
PMB2219, New York, NY 10018
+1 646-878-6329
IT Unit No. 504, 5th Floor, Icon
Tower, Baner, Pune - 411045.
+91 906 779 3500





Triglycerides testing reagents are used in the diagnosis and treatment of various diseases including lipid metabolism and hormonal disorders. Disease like diabetes mellitus, liver obstruction, and nephrosis are the prime areas for the use of triglycerides testing reagents.
Nowadays, Triglycerides testing reagents are used in the diagnosis of heart attack or stroke. Triglycerides testing reagents kits contains, free glycerol reagent, which is important for the colorimetric determination of fats in the blood. The triglycerides testing reagents is also available in the market separately, other than the kit.
The triglycerides testing reagents hydrolyzes the triglycerides to glycerol which are measured in the colorimetric test. This single Triglycerides testing reagents method, determine the total glycerides in the serum which includes the mono and diglycerides, and the free glycerol fractions.
When the Triglycerides testing reagents combines with the triglycerides in the body, formation of the colored complex, the intensity of the colored complex formed is directly proportional to the triglycerides concentration of the sample.
Rising patient pool suffering from obesity disorders may drive the Triglycerides testing reagents market. People suffering from disorders like indigestion, gastroesophageal reflux disease (GERD) may show the fueling growth for Triglycerides testing reagents market.
Disease conditions like cardiovascular disorders, hypertension, Hyperlipidemia, vitamin deficiency, and malnutrition will show the additional demand of the Triglycerides testing reagents market. Alternative diagnosis methods like CT scan, endoscopy may show the slower growth for Triglycerides testing reagents market.
Awareness of the people about the cystic fibrosis and obesity-related disorders may show the stagnancy in the Triglycerides testing reagents market.